Viking Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
179.60
755.90
14,104.00
13,150.60
20,576.00
301,520
Other Current Assets
-
17.80
1,097.60
824.30
1,275.80
613
Total Current Assets
179.60
773.70
15,201.60
13,974.80
21,851.80
302,133
Long-Term Note Receivable
4.50
-
-
-
-
-
Other Assets
0.80
2,269.50
237.50
560.90
269.60
179
Total Assets
184.90
3,043.10
15,439.10
14,535.70
22,121.40
302,312
ST Debt & Current Portion LT Debt
46.90
363.00
-
3,269.60
3,450.50
Accounts Payable
74.10
1,830.70
-
1,203.90
1,529.90
Other Current Liabilities
6.50
20,323.30
1,976.80
2,003.10
3,676.10
Total Current Liabilities
127.50
22,517.10
1,976.80
6,476.50
8,656.60
Long-Term Debt
303.50
2,654.60
2,151.50
-
-
Other Liabilities
-
-
2,585.80
16.30
-
Total Liabilities
431.00
25,171.70
6,714.10
6,492.80
8,656.60
Common Equity (Total)
246.10
22,128.50
8,725.00
8,042.90
13,464.80
Total Shareholders' Equity
246.10
22,128.50
8,725.00
8,042.90
13,464.80
Total Equity
246.10
22,128.50
8,725.00
8,042.90
13,464.80
Liabilities & Shareholders' Equity
184.90
3,043.10
15,439.10
14,535.70
22,121.40
About Viking Therapeutics
View Profile
